• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期可手术非小细胞肺癌的根治性放疗

Curative radiotherapy of early operable non-small cell lung cancer.

作者信息

Zhang H X, Yin W B, Zhang L J, Yang Z Y, Zhang Z X, Wang M, Chen D F, Gu X Z

机构信息

Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.

出版信息

Radiother Oncol. 1989 Feb;14(2):89-94. doi: 10.1016/0167-8140(89)90052-2.

DOI:10.1016/0167-8140(89)90052-2
PMID:2540510
Abstract

The results of 44 patients with early operable non-small cell lung cancer treated from January 1975 through 1981 are retrospectively analysed. All were proven by pathology and/or cytology and denied surgery in our joint Chest Clinic for various reasons. 55-70 Gy/6-7 weeks was delivered by conventional fractionation through A-P portals by telecobalt and/or 25-35 MeV high energy electron beam or 8 MV X-ray. 40 Gy/4 weeks was given prophylactically to the mediastinum. The 1-, 3-, and 5-year survival rates, 93, 55, and 32%, are superior to what is reported in the literature. In the present series, the favorable factors are: (1) patients without any intercurrent disease but refused operation; (2) T1 lesions; (3) complete regression of the lesion at the conclusion of radiotherapy; (4) doses ranging from 69 to 70 Gy. It is shown that early non-small cell lung cancer can be cured by radiotherapy alone giving survival rates comparable to surgery. Prospective randomized clinical trials are warranted.

摘要

对1975年1月至1981年期间接受治疗的44例早期可手术非小细胞肺癌患者的结果进行了回顾性分析。所有病例均经病理和/或细胞学证实,因各种原因在我们的联合胸部诊所被拒绝手术。通过远距离钴和/或25 - 35 MeV高能电子束或8 MV X射线经前后野以常规分割方式给予55 - 70 Gy/6 - 7周剂量。预防性地给予纵隔40 Gy/4周剂量。1年、3年和5年生存率分别为93%、55%和32%,优于文献报道。在本系列中,有利因素为:(1)无任何并发疾病但拒绝手术的患者;(2) T1期病变;(3)放疗结束时病变完全消退;(4)剂量范围为69至70 Gy。结果表明,早期非小细胞肺癌单纯放疗可治愈,生存率与手术相当。有必要进行前瞻性随机临床试验。

相似文献

1
Curative radiotherapy of early operable non-small cell lung cancer.早期可手术非小细胞肺癌的根治性放疗
Radiother Oncol. 1989 Feb;14(2):89-94. doi: 10.1016/0167-8140(89)90052-2.
2
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.单纯放疗用于医学上无法手术的Ⅰ期非小细胞肺癌:杜克大学的经验。
Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):149-54. doi: 10.1016/s0360-3016(97)00589-0.
3
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.非小细胞肺癌根治性放疗(>59 Gy)及同步化疗后的肺切除术
Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085.
4
[Prospective randomized trials comparing hyperfractionated radiotherapy with conventional radiotherapy in stage III non-small cell lung cancer].
Nihon Igaku Hoshasen Gakkai Zasshi. 1992 Oct 25;52(10):1452-5.
5
Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):119-130. doi: 10.1016/s0360-3016(02)02917-6.
6
Radiation therapy alone for stage I non-small cell lung cancer.I期非小细胞肺癌的单纯放射治疗。
Int J Radiat Oncol Biol Phys. 1993 Oct 20;27(3):517-23. doi: 10.1016/0360-3016(93)90374-5.
7
Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.加速放疗对无法手术的非小细胞肺癌(NSCLC)且无远处转移的临界预后因素患者的疗效:一项回顾性研究。
Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1053-6. doi: 10.1016/s0360-3016(99)00130-3.
8
N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group.N2期(临床)非小细胞肺癌:放射治疗肿瘤学组进行的总剂量60 Gy放射治疗的前瞻性试验。
Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):7-12. doi: 10.1016/0360-3016(91)90131-m.
9
Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).在非小细胞肺癌(NSCLC)患者的放疗(RT)期间,连续评估 FDG-PET 的 FDG 摄取和功能容积。
Radiother Oncol. 2012 Feb;102(2):251-7. doi: 10.1016/j.radonc.2011.07.023. Epub 2011 Aug 30.
10
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].[IV期非小细胞肺癌患者放疗后的生存状况——附287例报告]
Ai Zheng. 2006 Nov;25(11):1419-22.

引用本文的文献

1
The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.在放射治疗的背景下,癌症相关成纤维细胞与免疫细胞之间的相互作用。
Mol Carcinog. 2020 Jul;59(7):754-765. doi: 10.1002/mc.23205. Epub 2020 May 4.
2
A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER.用于帮助放射性肿瘤纵隔评估的预测模型:HOMER。
Am J Respir Crit Care Med. 2020 Jan 15;201(2):212-223. doi: 10.1164/rccm.201904-0831OC.
3
Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study.
饮酒与肺癌风险:国际肺癌联合会和 SYNERGY 研究的 pooled 分析。
Cancer Epidemiol. 2019 Feb;58:25-32. doi: 10.1016/j.canep.2018.10.006. Epub 2018 Nov 13.
4
Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.早期非小细胞肺癌的立体定向体部放射治疗(SBRT):当代见解与进展
J Thorac Dis. 2018 Aug;10(Suppl 21):S2451-S2464. doi: 10.21037/jtd.2018.04.52.
5
Initial clinical experience with stereotactic lung radiotherapy, based on a biological model-driven prescription method.基于生物模型驱动的处方方法的立体定向肺部放射治疗的初步临床经验。
J Radiosurg SBRT. 2011;1(3):221-229.
6
Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis.对不适合联合治疗的II-III期非小细胞肺癌患者单纯进行超过60 Gy的根治性放疗:回顾性分析
Radiat Oncol. 2015 Dec 3;10:250. doi: 10.1186/s13014-015-0560-z.
7
Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer.放疗治疗未切除的 I 期和 II 期老年非小细胞肺癌患者的疗效。
Am J Respir Crit Care Med. 2010 Feb 1;181(3):264-9. doi: 10.1164/rccm.200907-1064OC. Epub 2009 Nov 5.
8
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.对不适合手术或拒绝手术(医学上无法手术)的Ⅰ/Ⅱ期非小细胞肺癌患者进行根治性放疗:一项系统评价
Thorax. 2001 Aug;56(8):628-38. doi: 10.1136/thorax.56.8.628.
9
Video-assisted thoracoscopic wedge resection of T1 lung cancer in high-risk patients.高危患者T1期肺癌的电视辅助胸腔镜楔形切除术
Ann Surg. 1993 Oct;218(4):555-8; discussion 558-60. doi: 10.1097/00000658-199310000-00015.
10
Radiotherapy in the management of non-small-cell lung cancer.非小细胞肺癌治疗中的放射疗法。
World J Surg. 1993 Nov-Dec;17(6):741-50. doi: 10.1007/BF01659084.